Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl D Regillo

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
American Journal of Ophthalmology|September 28, 2014
Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edemaNadim Rayess, Ehsan Rahimy, Gui-Shuang Ying, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular EdemaDarius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal DetachmentVikram J Setlur, Nadim Rayess, Sunir J Garg, et al.
American Journal of Ophthalmology|January 10, 2016
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular EdemaEhsan Rahimy, Abtin Shahlaee, M Ali Khan, et al.
Ophthalmology|July 31, 2012
Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factorsAlok S Bansal, Jason Hsu, Sunir J Garg, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|March 24, 2010
Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitorsJustis P Ehlers, Marc J Spirn, Chirag P Shah, et al.
Retina (Philadelphia, Pa.)|November 2, 2016
RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award LectureCarol L Shields, Emil A T Say, Maria Pefkianaki, et al.
Journal of Vitreoretinal Diseases|September 25, 2024
Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal DiseasesCharles C Wykoff, Baruch D Kuppermann, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabDavid R Fintak, Gaurav K Shah, Kevin J Blinder, et al.
Journal of Vitreoretinal Diseases|January 15, 2024
OCT-Based Description of Spontaneous Reattachment of Macula-Off Tractional Retinal Detachment With Significant Vision ImprovementRaziyeh Mahmoudzadeh, John E Williamson, Mirataollah Salabati, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
American Journal of Ophthalmology|September 28, 2014
Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edemaNadim Rayess, Ehsan Rahimy, Gui-Shuang Ying, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular EdemaDarius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal DetachmentVikram J Setlur, Nadim Rayess, Sunir J Garg, et al.
American Journal of Ophthalmology|January 10, 2016
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular EdemaEhsan Rahimy, Abtin Shahlaee, M Ali Khan, et al.
Ophthalmology|July 31, 2012
Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factorsAlok S Bansal, Jason Hsu, Sunir J Garg, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|March 24, 2010
Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitorsJustis P Ehlers, Marc J Spirn, Chirag P Shah, et al.
Retina (Philadelphia, Pa.)|November 2, 2016
RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award LectureCarol L Shields, Emil A T Say, Maria Pefkianaki, et al.
Journal of Vitreoretinal Diseases|September 25, 2024
Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal DiseasesCharles C Wykoff, Baruch D Kuppermann, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabDavid R Fintak, Gaurav K Shah, Kevin J Blinder, et al.
Journal of Vitreoretinal Diseases|January 15, 2024
OCT-Based Description of Spontaneous Reattachment of Macula-Off Tractional Retinal Detachment With Significant Vision ImprovementRaziyeh Mahmoudzadeh, John E Williamson, Mirataollah Salabati, et al.
Pageof 15